A number of steroids seem to have anesthetic effects resulting primarily from their ability to potentiate currents gated by ␥-aminobutyric acid A (GABA A ) receptor activation. One such compound is (3␣,5␣,17␤)-3-hydroxyandrostane-17-carbonitrile [(ϩ)-ACN]. We were interested in whether carbonitrile substitution at other ring positions might result in other pharmacological consequences. Here we examine effects of (3␤,5␣ , current with reasonably high affinity and selectivity. Further study of steroid actions on T currents may lead to even more selective and potent agents.
of T current (44% maximal block) with an IC 50 value of 0.4 M. Block of T current showed mild use-and voltage-dependence. The (Ϫ)-ECN enantiomer was about 33 times less potent than (ϩ)-ECN, with an IC 50 value of 10 M and an amount of maximal block comparable to (ϩ)-ECN. (ϩ)-ECN was less effective at blocking high-voltage-activated Ca 2ϩ current in DRG neurons (IC 50 value of 9.3 M with maximal block of about 27%) and hippocampal neurons. (ϩ)-ECN (10 M) had minimal effects on voltage-gated sodium and potassium currents in rat chromaffin cells. The results identify a steroid with no effects on GABA A receptors that produces a partial inhibition of T-type Ca 2ϩ current with reasonably high affinity and selectivity. Further study of steroid actions on T currents may lead to even more selective and potent agents.
Because low-voltage-activated, or T-type, calcium (Ca 2ϩ ) currents are activated at potentials as negative as Ϫ60 mV, they are thought to play a key role in the initiation of regenerative depolarizing inward current (reviewed by Huguenard, 1996) . The properties of T currents and their distribution in particular cell types suggest a critical role in the regulation of excitability in both neurons (Llinas, 1988; Huguenard and Prince, 1992) and other excitable cells (Matteson and Armstrong, 1984; Hirano et al., 1989) . T currents have also been proposed to contribute to initiation of seizure activity in thalamic neurons (Huguenard and Prince, 1994; Tsakiridou et al., 1995) . Thus, physiological regulation of T-type current is likely to be of profound significance to the regulation of neuronal activity.
In contrast to the abundance of peptide toxins that have proven useful in identifying the physiological roles of HVA variants of Ca 2ϩ current (review by DeWaard et al., 1996) , there is an absence of highly potent and selective antagonists for T-type channels. Except for recent reports of the T-current blocking effects of mibefradil (Mishra and Hermsmeyer, 1994) , a compound which also affects HVA types of Ca 2ϩ current at somewhat higher concentrations (Bezprozvanny and Tsien, 1995) , most other T current blockers are of relatively weak potency and selectivity. However, T-type currents are blocked at high concentrations by a variety of compounds within concentrations that are perhaps clinically relevant. This includes anesthetics (Herrington et al., 1991; Study, 1994; Todorovic and Lingle, 1998) and also some anticonvulsants [e.g., succinimides (Coulter et al., 1989a (Coulter et al., , 1989b ; but see Leresche et al., 1998) and phenytoin ]. Selective blockers of T-currents are therefore likely to have interesting and important consequences on neuronal excitability and may be of unique clinical use.
The modulation of ion channel function by steroids is an area of increasing interest. Much of this interest has been focused on the modulation of GABA A receptor function by steroids (reviewed by Lambert et al., 1995) . With regard to Ca 2ϩ channel modulation, some steroids have been reported to modulate Ca 2ϩ currents through G-protein-mediated pathways (ffrench-Mullen et al., 1994) . Additionally, we have shown that (ϩ)-ACN ( Fig. 1) , a steroid that powerfully potentiates and gates GABA A receptors (Wittmer et al., 1996) , exerts somewhat selective, direct blocking effects on particular components of HVA Ca 2ϩ currents (Nakashima et al., 1998) . As part of ongoing structure-activity studies, we are examining other steroids for effects on Ca 2ϩ currents. Here we describe the effects of (ϩ)-ECN. (ϩ)-ECN is a 5␣-reduced steroid without a C-19 methyl group (a 19-norsteroid). Relative to (ϩ)-ACN, the ring positions of the carbonitrile and hydroxyl groups are reversed. The stereochemical relationship between these two groups is also different.
The main finding of this study is that (ϩ)-ECN ( Fig. 1 ), which has no effect on GABA receptors at 10 M, is a potent, enantioselective, partial blocker of T-type current in rat DRG sensory neurons. Furthermore, we compare the blocking effects of (ϩ)-ECN to the action of two other steroids that exhibit anesthetic effects, (ϩ)-ACN and alphaxalone. Although all three compounds share similarities in their effects on T type currents, (ϩ)-ECN is unique in lacking any effect on GABA A receptors. Steroid analogues that exhibit relatively selective, potent, and reversible effects on T currents, without any effects on GABA receptors, may provide useful tools for examining the role of T currents in neuronal excitability and aid the potential development of compounds that may mediate anesthetic, analgesic, or anticonvulsant effects.
Materials and Methods
Preparation of cells. Acutely dissociated DRG neurons from adult male Sprague-Dawley rats (100-300 g) were obtained using enzymatic treatment as described elsewhere . Glass coverslips with adherent DRG cells were transferred to a standard culture dish with a total volume Ͻ1 ml. Most results from DRG neurons were obtained from smaller diameter cells with no visible processes. Average uncompensated R s was 6.6 Ϯ 2.5 M⍀ (mean Ϯ standard deviation) and average C m was 13.5 Ϯ 4 pF for 217 neurons.
Microisland cultures of neonatal rat hippocampal neurons were prepared as described previously (Mennerick et al., 1995) . Cells used for recordings of HVA Ca 2ϩ currents were used after 2-5 days in culture. Chromaffin cells were prepared from adult rat adrenal glands as described elsewhere (e.g., Solaro et al., 1995) .
Electrophysiological methods, solution application, and current isolation procedures. Currents were recorded using standard whole-cell patch-clamp methods (Hamill et al., 1981) . Solutions were applied to cells through multiple independently controlled glass capillary tubes, and solution was removed from the other end of the chamber with the use of constant suction. Solution application was accomplished by manually controlled valves. Test solutions were maintained in all-glass syringes and allowed to fall by gravity. Changes in Ca 2ϩ current amplitude in response to rapidly acting drugs or ionic changes were typically complete in 10-20 sec. Switching between separate perfusion syringes, each containing control saline, resulted in no changes in Ca 2ϩ current. For all steroids examined here, no dependence on the order of presentation or desensitization with repeated applications was observed.
The intracellular saline for recording of T current consisted of: 135-140 mM tetramethylammonium hydroxide, 10 mM EGTA, 40 mM HEPES, and 2 mM MgCl 2 . The intracellular saline was usually titrated to pH 7.15-7.20 with HF, although in some experiments HCl or methanesulfonic acid was used. HVA currents were blocked by procedures described previously . Specifically, experiments on T currents were done on smaller DRG neurons that express L-and N-type HVA current almost exclusively (Scroggs and Fox, 1992) . Thus, in most experiments, the addition of F Ϫ to the intracellular solution was used to abolish L-type HVA current as described previously (Herrington and Lingle, 1992; Todorovic and Lingle, 1998) . In addition, such cells were preincubated with 1 M GVIA to abolish N-type HVA current. For generation of concentration-response curves, T currents were elicited by voltage steps to Ϫ30 mV from a holding potential of Ϫ90 mV. This resulted in T current with minimal HVA current contamination (e.g., Todorovic and Lingle, 1998) .
For recording of HVA currents, cells were held at Ϫ60 mV and inward currents were elicited by a test step to Ϫ10 mV. For HVA currents, the intracellular solution contained: 110 mM Cs-methane sulfonate, 14 mM phosphocreatine, 10 mM HEPES, 9 mM EGTA, 5 mM Mg-ATP, and 0.3 mM Tris-GTP, pH adjusted to 7.15-7.20 with CsOH (standard osmolarity: 300 mOsM). To verify that the composition of the intracellular solution did not influence the sensitivity of T currents to steroid action, in some experiments, the internal saline used for recording HVA currents was also used for recording of T current. In such cases, to isolate T current, HVA current was blocked by preincubation of cells with 1 M GVIA, and by also including 2 M MVIIC and 5 M nifedipine in the external solution, to block N-, P-, Q-and L-types of HVA current, respectively. The blocking effects of steroids on T current were identical with all of the procedures used to isolate T current, regardless of whether the intracellular anion was F Ϫ , methanesulfonic acid, or Cl Ϫ . 
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The standard extracellular saline for recording of T-type Ca 2ϩ currents contained: 152 mM tetraethylammonium-Cl, 10 mM HEPES, and 10 mM BaCl 2 , adjusted to pH 7.4 with tetraethylammonium-OH, osmolarity 316 mOsM. For recording of HVA Ca 2ϩ currents in DRG neurons, a 5 mM Ba 2ϩ solution was used. Recordings of HVA Ba 2ϩ current in cultured hippocampal neurons followed procedures described previously (Nakashima et al., 1998) .
Recordings of GABA currents on cultured hippocampal neurons were done as described previously (Mennerick et al., 1995; Wittmer et al., 1996) . The extracellular recording solution contained: 140 mM NaCl, 4 mM KCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, pH 7.3. Recording pipettes were filled with a solution containing: 140 mM CsCl, 4 mM NaCl, 5 mM EGTA, 0.5 mM CaCl 2 , 4 mM MgCl 2 , and 10 mM HEPES, pH 7.3. In studies examining autaptic currents, CsCl was replaced by KCl and MgCl 2 was replaced with 2 mM Mg-ATP and 0.5 mM Na-GTP in the intracellular solution. GABA and steroids were applied for 500 msec using a pressure (20 p.s.i. air) ejection drug delivery system with a patch pipette positioned approximately 5 m from the neuron. The concentrations reported here are those in the pipette and are an upper limit for the concentrations reaching the cell. Autaptic responses were evoked from a holding potential of Ϫ70 mV using 1.5-msec voltage steps to ϩ20 mV applied every 30 sec.
To record Na ϩ and K ϩ currents from chromaffin cells, the external saline contained: 140 mM NaCl, 5.4 mM KCl, 10 mM HEPES, 1.8 mM CaCl 2 and 2.0 mM MgCl 2 titrated to pH 7.4 with N-methylglucamine. For recording of Na ϩ currents, the internal saline was identical to the one for HVA Ca 2ϩ currents used for DRG neurons. Analysis of steroid effects on current amplitude and properties. The percent reduction in peak inward current carried by Ba 2ϩ ions at a given steroid concentration was used to generate concentration-response curves. For each of these curves, all points are averages of multiple determinations obtained from at least five different cells. Only cells where at least two different concentrations of the same steroid were tested were used to construct concentrationresponse curves. Because the level of maximal block by different steroids was somewhat variable from cell to cell, only those cells in which a drug concentration producing a near maximal effect was tested were taken for analysis. On all concentration-response curves, vertical bars indicate standard errors. Mean values on all concentration-response curves were fit to the following function:
where PB max is the maximal percent block of peak T current, IC 50 is the concentration that produces 50% of maximal inhibition, and n is the apparent Hill coefficient for blockade. Fitted values are reported with 95% linear confidence limits. The voltage-dependence of steady state inactivation was described with Boltzmann distribution:
where I max represents maximal activatable current, V 0.5 represents the voltage where half of the current is inactivated, and k (units of millivolts) represents the voltage dependence of the distribution. Effects of (ϩ)-ECN on current activation and inactivation time constants ( m and h , respectively) were determined from the fit of the following form of a Hodgkin and Huxley (1952) 
where I(t) is the current (I) as a function of time (t), A is the maximal activatable current, m is the activation time constant, h is the inactivation time constant, and n is a term for the sigmoidicity in the activation process. For T current at potentials more positive than Ϫ20 mV, n was typically constrained to 1.0. In the absence of such constraint, for currents between Ϫ60 and 0 mV, n varied from about 1.8 to about 1.0. Drugs and chemicals. The synthesis of (ϩ)-ECN and (Ϫ)-ECN will be described elsewhere. The compounds had spectroscopic data (IR, NMR) consistent with the assigned structures and were shown to have the correct elemental composition by combustion analysis for C, H, and N. The preparation of (ϩ)-ACN (Hu et al., 1993) and (Ϫ)-ACN (Hu et al., 1997) have been described previously. Alphaxalone was obtained from Sigma (St. Louis, MO). All steroids were dissolved in DMSO to make 10-30 mM stock solutions. Aliquots of the stock solutions were added to the standard external solution to make the final concentrations given in the text. The final concentration of DMSO was less than 0.6% in these experiments; this concentration of DMSO did not affect I Ba (data not shown, n ϭ 5 cells) or GABA A currents. At steroid concentrations of 60 M or higher, the steroids seem to crystallize out of solution, thus reducing the effective steroid concentration in solution. This has prevented us from using higher concentrations of steroids in experiments where maximal blockade could not be determined reliably.
GVIA (RBI, Natick, MA; Sigma) and MVIIC (RBI; Sigma) were dissolved in distilled water to make stock solutions of 0.5, 0.5 and 0.2 mM, respectively. Nifedipine (RBI) was dissolved in DMSO at 5 mM as a stock solution. GDP␤S and GTP␥S were obtained from Sigma and, when used, replaced GTP in the pipette solution.
Results
(؉)-ECN does not potentiate GABA currents in rat hippocampal neurons. Fig. 1 displays the structures of the various steroids used in this investigation. A feature of many neuroactive steroids is their ability to potentiate GABA Areceptor mediated Cl Ϫ currents (Lambert et al., 1995; Wittmer et al., 1996) . Both (ϩ)-ACN (Wittmer et al., 1996) and alphaxalone (Sear, 1996) are anesthetic steroids whose effects are thought to be mediated by GABA A -receptor potentiation.
The effects of (ϩ)-ECN on GABA A -receptor-mediated currents were examined in cultured neonatal hippocampal neurons grown in microisland cultures ( Fig. 2A) . (ϩ)-ECN (10 M) was totally without effect on currents activated by 2 M GABA. For comparison, 10 M (ϩ)-ACN produces a large potentiation of currents activated by 2 M GABA ( Fig. 2B ; Wittmer et al., 1996) . (Ϫ)-ECN does not produce any significant potentiation of GABA A -mediated currents at 10 M (not shown), whereas (Ϫ)-ACN produces some potentiation (Wittmer et al., 1996) .
To ascertain other potential targets of (ϩ)-ECN action, we also examined the effects of 10 M (ϩ)-ECN on autaptically evoked synaptic currents in the hippocampal microisland cultures (Mennerick et al., 1995) . (ϩ)-ECN (10 M) had no effect on either GABA-mediated inhibitory synaptic currents ( Fig. 2C ; two experiments) or glutamate-mediated excitatory synaptic currents ( Fig. 2D ; four experiments).
(؉)-ECN inhibits T-type Ca 2؉ current in rat DRG neurons. T-type Ca 2ϩ currents were isolated as described in Materials and Methods and typically monitored with voltagesteps to Ϫ30 mV from a holding potential of Ϫ90 mV. (ϩ)-ECN reversibly depressed the amplitude of T current as seen in Fig. 3A without apparent effects on current activation or inactivation kinetics. Blockade by (ϩ)-ECN was concentration-dependent ( Fig. 3C , where 10 M (ϩ)-ECN blocked about 2-fold more T-type current than the same concentration of (Ϫ)-ECN. No apparent desensitization was obvious when cells were exposed sequentially to the same concentration of steroid. From such experiments, concentration-response curves for both agents were generated as depicted in Fig. 3D . In each cell, responses to any application of steroid were normalized to blockade produced by 10 M (ϩ)-ECN. For (ϩ)-ECN, the IC 50 for blockade of T-type Ca 2ϩ current was 0.3 Ϯ 0.02 M with a Hill coefficient of 0.98 Ϯ 0.07 (n ϭ 15 cells). (Ϫ)-ECN was about 30-fold less potent with an IC 50 value of 10 Ϯ 1.6 M and a Hill coefficient of 1.2 Ϯ 0.2 (n ϭ 10 cells). At concentrations producing maximal block, both compounds were about equally efficacious.
The partial blockade of T current by (ϩ)-ECN raises the question of whether the blocking effect of (ϩ)-ECN is directly on the T channel or via some modulatory pathway regulating T-current behavior. Four observations suggest that (ϩ)-ECN does, in fact, block T current directly. First, T current inhibition by a given concentration of (ϩ)-ECN is readily reversible and reproducible over sequential applications. Inhibition of Ca 2ϩ currents by G-protein mediated pathways often exhibits a characteristic desensitization (Ikeda and Schofield, 1989; Shapiro and Hille, 1993) . Second, the blocking effect of (ϩ)-ECN was observed with an intracellular saline that lacked either ATP or GTP, two constituents deemed necessary for maintenance of second-messenger mediated signaling pathways. Third, the addition of either 100 M GTP␥S or 2 mM GDP␤S to the pipette saline did not alter the ability of (ϩ)-ECN to inhibit T current. With GTP␥S, 10 M (ϩ)-ECN blocked 34.5 Ϯ 3.2% (four experiments) of the T current. With GDP␤S, 10 M ECN inhibited 36.3 Ϯ 3.2% (three experiments) of the T current. Neither GTP␥S or GDP␤S resulted in appreciable run-down or run-up of T current. Finally, the presence or absence of F Ϫ in the intracellular saline, an anion which stimulates many G-proteins, did not influence the blocking actions of (ϩ)-ECN. However, we did observe some variability among cells in the maximal blocking effect of (ϩ)-ECN on T current. This might occur if T current were partially contaminated by inactivating, (ϩ)-ECN-resistant HVA current. Alternatively, the blocking mechanism may involve state-dependent features, perhaps influenced by modulatory pathways, which may exhibit cell-to-cell variability.
Blockade by (؉)-ECN produces little change in T current kinetic behavior but exhibits mild voltageand use-dependence. Many compounds are thought to inhibit ion channels either by plugging the ion permeation or by producing allosteric changes in channel gating, such that inactivated or closed states are favored. Such effects are often revealed by kinetic alterations in the channel gating behav- 2ϩ currents activated from a holding potential of Ϫ90 mV to a test potential of Ϫ30 mV before, during and after application of 10 M (ϩ)-ECN. Note that current activation and inactivation rates are not obviously altered by (ϩ)-ECN, despite the ϳ37% reduction in current amplitude. All current amplitudes are measured from the peak current to the current amplitude at the end of test pulse. C m , 20 pF; R s , 10 M⍀. B, The peak T current amplitude is plotted over the course of an experiment in which three different concentrations of (ϩ)-ECN were applied to a DRG neuron (C m, 17 pF; R s, 11 M⍀). Horizontal bars, times of steroid application. Note that 30 M steroid did not depress peak current amplitude more than that by 10 M. C, Block of T current by identical concentrations of the (ϩ) 
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Effects of (ϩ)-ECN on T-current deactivation were examined at potentials from Ϫ160 through Ϫ60 mV following a 15-msec depolarizing step to Ϫ30 mV. Tail currents were reasonably well described by single exponential functions over this range and 10 M (ϩ)-ECN had no obvious effect on current deactivation (Fig. 4A) . Current activation time constants were determined from fits of a Hodgkin-Huxley model (eq. 3) to T currents activated during a 380-msec depolarizing step to potentials between Ϫ65 mV and ϩ30 mV. Values for n ranged from 2.0 to near 1.0, being near 1.0 at potentials of Ϫ20 mV and more positive. Thus, the Hodgkin-Huxley term m approximates a single exponential fit to the rising phase of the current. (ϩ)-ECN (10 M) had no obvious effect on the rates of T current activation.
Potential effects of (ϩ)-ECN on the rate of current inactivation were also determined from the value of h in the fit of eq. 3 to the current waveforms. Values plotted in Fig. 4B indicate that 10 M (ϩ)-ECN had no significant effect on the time constant of current inactivation.
Recovery from inactivation was examined with a pairedpulse protocol in which a 100-msec step to Ϫ30 mV was first used to inactivate most T current. After a variable recovery interval (25 to 10,000 msec) at either Ϫ90 mV or Ϫ130 mV, a second test step to Ϫ30 mV was used to determine the amount of T current that had recovered from inactivation during the recovery period. The percent recovery in the presence and absence of 10 M (ϩ)-ECN for four cells was then plotted as a function of recovery duration at either Ϫ90 mV (Fig. 4C) or Ϫ130 mV (Fig. 4D) . Recovery time courses with and without (ϩ)-ECN were best fit with two exponential components with values given in the legend of Fig. 4 . The time constants of recovery are similar both with and without (ϩ)-ECN. However, the relative amplitude of the fast recovery component is somewhat smaller in (ϩ)-ECN, resulting in a somewhat slower overall recovery.
We next determined whether (ϩ)-ECN might alter T current availability at different conditioning potentials. T currents were evoked by a voltage-step to Ϫ30 mV after a 5-sec conditioning step at potentials from Ϫ110 to Ϫ55 mV in the presence and absence of 10 M (ϩ)-ECN (Fig. 5A ). This procedure defines the voltage-dependence of T-current fractional availability . Fig. 5A shows that 10 M (ϩ)-ECN reduced T current elicited from negative potentials by almost 50%. The normalized maximal current elicited from each conditioning potential is plotted as a function of the conditioning potential in Fig. 5B for a set of eight cells. Fig. 5B , solid lines, represent the best fits from the Boltzmann equation (eq. 2); for control conditions, half availability occurred at Ϫ78 mV with slope factor of 8 mV, whereas in the presence of 10 M (ϩ)-ECN, the V 0.5 was Ϫ85.5 mV with a slope factor of 8.8 mV. These experiments indicate that (ϩ)-ECN exerts a somewhat stronger blocking effect at more positive conditioning potentials, but the effect is rather small. The slight slowing of recovery from inactivation observed in Fig. 4 , C and D, might contribute to the effect of (ϩ)-ECN on steady state inactivation.
The dependence of the fractional block of T current by (ϩ)-ECN on T current stimulation frequency was also examined. In control conditions, when T currents are activated by 250-msec depolarizations applied every 20 or 5 sec, no change in peak T current amplitude is noted (Fig. 5C ). However, in the presence of 10 M (ϩ)-ECN, activation of T current at 1 per 5 sec increases the amount of blockade by (ϩ)-ECN by about 25% relative to blockade at 1 per 20 sec. The average increase in block (when cells are stimulated every 20 versus every 5 sec) was 25 Ϯ 8% (mean Ϯ standard deviation) (n ϭ 7 cells) for 10 M (ϩ)-ECN. This result is consistent with the somewhat stronger blockade of T current by (ϩ)-ECN at more positive potentials. At higher stimulation frequencies, the recovery time at Ϫ90 mV is insufficient to allow full recovery from the blockade developed at Ϫ10 mV.
(؉)-ECN is relatively ineffective at blocking HVA current in rat DRG neurons. A number of steroids have been reported to inhibit HVA types of Ca 2ϩ currents (ffrench- values from eq. 3. C, Percent recovery of peak inactivating current is plotted as a function of recovery duration at Ϫ90 mV. Symbols, mean Ϯ standard deviation for four cells. Solid line is single exponential fit, whereas dotted line is two exponential fit. Non-zero initial recovery reflects incomplete T current inactivation during initial 100-msec step to Ϫ30 mV and/or some unblocked, noninactivating HVA current contamination of the peak current amplitude. For single exponential fits, recovery time constants were 448.9 Ϯ 59.1 msec (control) and 619. et al., 1998) . To examine the effectiveness of (ϩ)-ECN on HVA current, cells were held at Ϫ60 mV and largely noninactivating currents were evoked by depolarizing steps to Ϫ10 mV. HVA current in these cells was composed primarily of nifedipine-sensitive L-type current and GVIA-sensitive N-type current (Scroggs and Fox, 1992; Todorovic and Lingle, 1998) . In Fig. 6A , a cell that exhibited both T-type and HVA current is depicted. T-type current was initially evoked by a test step to Ϫ40 mV from a holding potential of Ϫ90 mV; after return to a holding potential of Ϫ50 mV, a step to 0 mV resulted in activation of a largely noninactivating HVA current. (ϩ)-ECN (1 M) produced a partial inhibition of the peak T current but had no effect on current activated by the subsequent step to 0 mV. Fig. 6B illustrates traces of HVA currents from the same cell before, during, and after application of 30 M (ϩ)-ECN, which produced a reversible, 22% reduction of HVA current. Fig. 6C illustrates the time course of HVA current blockade in another rat DRG cell. (ϩ)-ECN (3, 30, and 60 M) reversibly reduced the peak HVA current amplitude in a concentration-dependent manner with a maximal block of about 27%. In this cell, 1 M GVIA irreversibly blocked about 16% of the total HVA current indicative of N-type current blockade, whereas 5 M Nifedipine (an "L" type antagonist) blocked most of the remaining HVA current in this cell. For this cell, this result indicates that at least most of the current blocked by 60 M (ϩ)-ECN is primarily L-type current. Fig. 5D displays the concentration-response curve for blockade of total HVA current by (ϩ)-ECN in rat DRG cells. All points are an average of at least five cells (total n ϭ 11 cells). In Fig. 5D , the solid line is a best fit of eq. 1, yielding an IC 50 value of 9.3 Ϯ 2.7 M, with a Hill coefficient of 1.2 Ϯ 0.3 and a fitted maximal block of 27.6 Ϯ 3%. In other experiments, the effect of (ϩ)-ECN was examined on isolated N-or L-type HVA current. For these experiments, small DRG neurons, which express predominantly N-and L-type HVA currents (Scroggs and Fox, 1992) , were used. For five DRG neurons in which N-type current was abolished with 1 M GVIA, (ϩ)-ECN blocked a maximum of 37 Ϯ 8% of the residual, predominantly L-type current with an IC 50
Fig. 5. Availability of T current for activation is influenced by (ϩ)-ECN.
A, Traces show currents activated by voltage steps to Ϫ10 mV after a 5-sec step to potentials from Ϫ110 through Ϫ55 mV either in control saline (top) or 10 M (ϩ)-ECN (bottom). C m, 16 pF; R s, 10 M⍀. B, The average fractional availability of T current as a function of voltage is plotted for control and 10 M (ϩ)-ECN for eight cells. Error bars, mean Ϯ standard error; solid lines, best fit of eq. 1. For control saline, half inactivation occurred at Ϫ78 mV with a slope factor of 8 mV; in the presence of 10 M (ϩ)-ECN, the V 0.5 was Ϫ85.5 mV with a slope factor of 8.8. C, T currents were elicited once every 5 sec or once every 20 sec, in the absence and presence of 10 M (ϩ)-ECN. The change in stimulus frequency has no effect on T current amplitude under control conditions, but in the presence of (ϩ)-ECN, peak T current amplitude is reduced at higher stimulus frequencies (C m , 13 pF; R s , 12 M⍀). Currents were activated with the voltage protocol shown on the top. A step to Ϫ40 mV was used to activate and inactivate T current; after repolarization to Ϫ50 mV, a step to 0 mV was used to activate HVA current. (ϩ)-ECN (1 M) blocks about 20% of the inactivating current at Ϫ30 mV but has no effect on current activated at 0 mV. Note the different time bases used for acquisition of LVA and HVA currents. Vertical calibration bar, time at which the sampling interval was changed from 0.8 msec to 0.1 msec. B, Traces show currents activated from a voltage step to Ϫ10 mV from a holding potential of Ϫ60 mV before, during, and after application of 30 M (ϩ)-ECN from the same cell used in A. About 22% of the total HVA current was blocked. C m , 10 pF; R s , 5 M⍀. In C, a time record of peak HVA current amplitude from another DRG cell shows the relative blocking effect of 3, 30, and 60 M (ϩ)-ECN. Horizontal bars, times of steroid application. Note that 60 M steroid blocked only slightly more current than 30 M. Comparing the effect of GVIA and nifedipine indicates that most HVA current in this cell was of L-type. C m , 17 pF; R s , 9 M⍀. D, The concentration-dependence of blockade of total HVA current by (ϩ)-ECN is displayed. Smaller size DRG cells containing primarily Nand L-type Ca 2ϩ currents were used (Scroggs and Fox, 1992) . Points, averages of at least five different cells; vertical lines, mean Ϯ standard error. Solid line, best fit of eq. 1, yielding an IC 50 value of 9.3 Ϯ 2.7 M, a Hill coefficient of 1.2 Ϯ 0.3, and maximal block of 27.6 Ϯ 3% (8 cells).
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value of 12.7 Ϯ 6.6 M (n ϭ 1.6 Ϯ 0.8). For five DRG neurons in which L-type current was abolished by a combination of intracellular F Ϫ and application of 5 M nifedipine, (ϩ)-ECN blocked a maximum of 44 Ϯ 4.6% of the residual, predominantly N-type current with an IC 50 value of 8.7 Ϯ 2.1 M (n ϭ 1.5 Ϯ 0.4). Thus, both N-and L-type current are only weakly sensitive to (ϩ)-ECN.
We also examined the effects of (ϩ)-ECN on total HVA current in cultured neonatal rat hippocampal neurons. In such neurons, HVA current is typically composed of at least 5 distinguishable components. (ϩ)-ACN has previously been shown to block N-, Q-, and R-types of HVA current in these cells, with IC 50 values of 10-25 M, but does not affect L-and P-type current (Nakashima et al., 1998) . Here, we simply compared the block produced by 30 M (ϩ)-ECN with that produced by 30 M (ϩ)-ACN. 30 M (ϩ)-ECN blocked an average of 21.1 Ϯ 3.5% of total HVA current (n ϭ 5) (data not shown), whereas effects of 10 M (ϩ)-ECN on HVA current were difficult to discern. Blockade by 30 M (ϩ)-ECN was 50.2 Ϯ 4.5% of the blockade produced by 30 M (ϩ)-ACN. Thus, in sum, (ϩ)-ECN seems to produce partial blocking effects on some HVA current components, but with relatively weak effects at less than 10 M.
The effects of (؉)-ECN on voltage-gated Na ؉ and K ؉ currents in rat chromaffin cells. We next examined the effects of (ϩ)-ECN on several other potential ion channel targets found in cultured adult rat adrenal chromaffin cells. Rat chromaffin cells express a robust, tetrodotoxin-sensitive voltage-dependent Na ϩ current. Fig. 7A shows voltagedependent Na ϩ current before and during application of escalating concentrations of (ϩ)-ECN. (ϩ)-ECN (30 M but not 1 and 10 M) produces a slight reduction (ϳ14%) in Na ϩ current amplitude. Fig. 7B plots the time course of Na ϩ current amplitude from the same experiment.
Rat chromaffin cells also express a robust BK-type Ca 2ϩ -and voltage-dependent K ϩ current which exhibits inactivation (Solaro et al., 1995) . This current can be observed in relative isolation by voltage steps to ϩ90 mV when the recording pipette contains 10 M Ca 2ϩ (Fig. 7C) . After inactivation of the BK current at ϩ90 mV, there is also a persistent voltage-dependent K ϩ current. Neither 10 nor 30 M (ϩ)-ECN had any effect on either the inactivating or sustained component of K ϩ current. The lack of effect of (ϩ)-ECN on either K ϩ current is also shown in Fig. 7D . From the above experiments, we conclude that at 10 M (ϩ)-ECN, a concentration maximally effective at blocking T current in rat DRG cells, there is no effect upon several other voltage-gated currents. Even at 30 M (ϩ)-ECN, effects on K ϩ currents are nonexistent with only minimal effects on Na ϩ current. The effects of alphaxalone and (؉)-ACN on T current in rat DRG cells. The enantioselectivity in the blocking effect of (ϩ)-ECN on T-type Ca 2ϩ current indicates that particular structural requirements are necessary for the blocking effect. Although a more thorough examination of the structural requirements of T-current block will be required, here we have examined the ability of three other steroids, alphaxalone, (ϩ)-ACN, and (Ϫ)-ACN, to block T-type calcium current in rat DRG cells.
Alphaxalone is the only steroid anesthetic that has been widely used in human medicine (Sear, 1996) . Fig. 8A shows traces of T current before, during, and after application of 30 M alphaxalone, which in this cell blocked about 50% of peak T current. Alphaxalone, in contrast to (ϩ)-ECN, is also a potent GABAergic agent (Lambert et al., 1995) . We were therefore concerned that the apparent reduction in outward current observed with alphaxalone might result from a GABA A -receptor mediated activation of a superimposed outward current. To test this possibility, DRG neurons were stimulated with voltage ramps from Ϫ90 to 90 mV (data not shown) in the presence of cadmium to completely block inward current. Subsequent application of alphaxalone failed to evoke any inward or outward current, indicating that the apparent effects of alphaxalone on T-current do not arise from coincidental activation of a Cl Ϫ current. The effect of alphaxalone on the T-current steady state inactivation curves was also examined. As shown on Fig. 8B , the V 0.5 for T-current availability was shifted from Ϫ79.5 mV to Ϫ88.5 mV, with slope factors of 7.7 mV and 9.4 mV in the absence and presence of this steroid, respectively (n ϭ 5 cells). The magnitude of this effect, although not profound, is comparable with the effect of (ϩ)-ECN on DRG T current. Also similar to the effect of (ϩ)-ECN, there was an increase in the fractional blockade by alphaxalone (26 Ϯ 9%; n ϭ 4 cells) as the frequency of stimulation of T current was increased Fig. 7 . Lack of effect of (ϩ)-ECN on voltage-dependent Na ϩ current (I Na ) and K ϩ currents in rat adrenal chromaffin cells. A, Traces show I Na activated by the indicated voltage protocol. Traces in 1 and 10 M (ϩ)-ECN are indistinguishable from control, whereas 30 M produced a ϳ14% reduction in I Na . B, Peak I Na amplitude during the course of an experiment indicates that any effects of (ϩ)-ECN are rather minor. C, Traces show outward currents evoked by steps to 90 mV from a holding potential of Ϫ110 mV with 10 M pipette Ca 2ϩ . The inactivating component of current is BK-type Ca 2ϩ dependent K ϩ current, whereas the residual noninactivating current reflects at least one other voltage-dependent K ϩ conductance. Neither current component was affected by either 10 or 30 M (ϩ)-ECN. D, Peak current amplitude is plotted as a function of experimental time illustrating the lack of effect of (ϩ)-ECN on both peak (F) and steady state (E) K ϩ current components. from every 20 to every 5 seconds (data not shown). Alphaxalone also shares with (ϩ)-ECN a lack of any discernible effect on T current activation or inactivation kinetics (data not shown). Blockade of T current by alphaxalone was concentrationdependent ( Fig. 8C) with an IC 50 value of 1.3 Ϯ 0.3 M, a Hill coefficient of 0.92 Ϯ 0.14, and maximal block of 55 Ϯ 12% (n ϭ 15 cells). Alphaxalone at 10 M had no effect on total HVA current in DRG cells ( Fig. 8D ; n ϭ 2 cells) and had minimal effect upon total HVA current in hippocampal neurons (only 7% block of total HVA current at 30 M; Nakashima et al., 1998).
(ϩ)-ACN is another steroid that, unlike (ϩ)-ECN, has significant effects upon GABA A receptors ( Fig. 2 ; Wittmer et al., 1996) . Potentiation of currents activated by 2 M GABA occurs with an EC 50 value of 1.4 M (ϩ)-ACN, whereas direct gating of GABA A receptor current by (ϩ)-ACN occurs with an EC 50 value of 5 M (Wittmer et al., 1996) . In addition, (ϩ)-ACN, in contrast to (ϩ)-ECN and alphaxalone, exhibits blocking effects on specific subtypes of HVA Ca 2ϩ currents in the range of 5-20 M (Nakashima et al., 1998) .
In rat DRG cells, we found that (ϩ)-ACN also produces enantioselective blockade of T currents. Maximal block was incomplete being about 40% and no increase in block was observed between 10 and 30 M (ϩ)-ACN (Fig. 9A) . Effects of 10 M (ϩ)-ACN on steady state T current availability were similar to effects seen with (ϩ)-ECN and alphaxalone (Fig.  9B ). Blockade by (ϩ)-ACN exhibited marked enantioselectivity (Fig. 9C) These results suggest that a number of steroids can block T current in DRG neurons with a high degree of enantioselectivity. Furthermore, the partial blockade of T current by these compounds, the lack of kinetic alterations by these compounds, and similar small shifts in steady state inactivation curves suggests that each of these compounds may block T current with a similar mechanism.
If different steroids were acting at different sites and by different mechanisms to produce blockade of T currents, some additivity in their blocking effects might be expected. To test this possibility, concentrations of (ϩ)-ACN and (ϩ)-ECN yielding near maximal blocking effects (10 M in each case) were coapplied on the same cell (n ϭ 7 cells; Fig. 9D ) and compared with responses to a 10 M concentration of each steroid alone. The amount of block when they were given together was not additive, which suggests that these Fig. 8 . Effects of alphaxalone on T currents in rat DRG cells. A, Traces show T current in a DRG cell before, during, and after application of 30 M alphaxalone. B, The effect of alphaxalone on fractional availability of DRG T current is illustrated. Solid lines, fits of eq. 2. Alphaxalone shifted the V 0.5 from Ϫ79.5 mV (control, open symbols) to Ϫ88.5 mV (alphaxalone, filled symbols) with slope factors of 7.7 mV (control) and 9.4 mV (alphaxalone) (n ϭ 5 cells). Error bars, mean Ϯ standard error. C, Concentration-response curves for percent inhibition of T current by alphaxalone are plotted. Points, average of at least five different cells; bars, mean Ϯ standard error. Solid line, best fit of eq. 1 with an IC 50 value of 1.3 Ϯ 0.3 M, a hill coefficient of 0.92 Ϯ 0.14, and a fitted maximal block of 62 Ϯ 4.5% (n ϭ 20 cells). D, HVA currents were activated by steps to Ϫ10 mV from Ϫ60 mV in the presence and absence of 10 M alphaxalone. Alphaxalone had no effect. 
Discussion
A novel neuroactive steroid, (ϩ)-ECN, produces a potent blockade of T-type Ca 2ϩ current in rat DRG neurons with 50% of the maximal blocking effect occurring at 0.3 M. This effect is strongly enantioselective; (Ϫ)-ECN is more than 30 times less potent. Maximal blockade by (ϩ)-ECN is only about 40% of total T current. Similarly, for all steroids studied here that do inhibit T current, maximal blockade was incomplete.
A number of other T current blockers have also been reported to produce an incomplete block at concentrations producing a maximal effect. For example, the anticonvulsants phenytoin and ␣-methyl-␣-phenyl-succinimide also block less than 50% of DRG T current . Partial block of other Ca 2ϩ channel variants has also been described and, in the case of blockade of P-type current by -agatoxin IIIA, it has been proposed that a partial reduction of the rate of ion permeation through the P-type channel may account for the partial blocking effects (Mintz, 1994) . In the case of T current block, the mechanism underlying the partial blockade produced by any compound remains unknown.
The anticonvulsant drug ethosuximide has been reported to block only about 40% of T current in thalamic neurons (Coulter et al., 1989a (Coulter et al., , 1989b . However, recent work has failed to identify any effect of 0.5 mM ethosuximide on T current in thalamic neurons (Leresche et al., 1998) . In fact, other work indicates that T current can be maximally blocked by ethosuximide in both GH3 cells (Herrington and Lingle, 1992) and DRG neurons , but only at concentrations (IC 50 ϳ 20 -30 mM) that greatly exceed those used clinically.
Selectivity in blockade by (؉)-ECN. In contrast to alphaxalone and (ϩ)-ACN, (ϩ)-ECN seems to be relatively selective in its ability to block T current and exerts little effect on other targets at comparable concentrations. Although maximal block of T current by (ϩ)-ECN is only partial, this block is of relatively high affinity, producing half maximal block at about 0.3 M. In contrast, at 10 M, (ϩ)-ECN has only small effects on HVA current in both rat DRG and hippocampal neurons. Providing additional support for the idea that (ϩ)-ECN is relatively ineffective against HVA currents, we have observed that (ϩ)-ECN has weak blocking effects on cloned human ␣1E Ca 2ϩ channels expressed in HEK cells (Nakashima Y, Pereverzev A, Schneider T, Covey DF, and Lingle CJ. Blockade of Ba 2ϩ current through human ␣1E channels by two steroid analogs, (ϩ)-ACN, and (ϩ)-ECN; submitted for publication.), blocking up to about 80% of the ␣1E current with an IC 50 value of about 19 M. Thus, HVA Ca 2ϩ currents seem to be largely unaffected by (ϩ)-ECN at concentrations (ϳ1 M) producing a near maximal effect on T currents. This apparently marked selectivity of (ϩ)-ECN is also supported by the lack of effect on voltage-gated Na ϩ and voltage dependent K ϩ current and Ca 2ϩ -dependent K ϩ current in rat chromaffin cells. (ϩ)-ECN therefore seems to exhibit a combination of potency and selectivity that may allow it to be of potential use in the pharmacological evaluation of T currents.
Blockade of T current by both (ϩ)-ECN and (ϩ)-ACN also exhibits strong enantioselectivity. This implies that the site affected by these steroids has quite specific structural requirements. Given the disparity in structure among (ϩ)-ECN, (ϩ)-ACN, and alphaxalone, is it possible that the blocking effects observed here represent effects on more than one target site? It is difficult to exclude this possibility. However, the fact that the blocking effects of (ϩ)-ACN and (ϩ)-ECN are not additive implies that, at least for these two structurally distinct steroids, there may be a common site and mechanism of action. Furthermore, several features of the block of T current produced by (ϩ)-ECN, alphaxalone, and (ϩ)-ACN support this view. In particular, all three compounds produce similar changes in steady state inactivation curves, each produces a partial block at maximal concentrations, and each has essentially no effect on kinetic properties of T currents. Although it is possible that each compound acting at distinct sites might result in this identical set of blocking characteristics, the simplest view at the present time is that they are acting at the same site. Despite the similarity in action of (ϩ)-ECN, (ϩ)-ACN, and alphaxalone on T-type current, the lack of effect of (ϩ)-ECN on GABA receptors seems particularly remarkable. There are multiple differences in the structures of (ϩ)-ACN and (ϩ)-ECN that might contribute to the selectivity of (ϩ)-ECN in producing T channel inhibition, while leaving many other steroid-sensitive targets unaffected. These differences include: 1) the positions of the hydroxy and carbonitrile groups; 2) the relative stereochemistry between these groups; 3) the presence or absence of a C-19 methyl group; and 4) the distances between the oxygen and nitrogen atoms. Each of these differences needs to be evaluated more fully in future studies to understand its contribution to the ion channel selectivity observed in this study for (ϩ)-ECN.
(ϩ)-ECN, (ϩ)-ACN, and alphaxalone also show interesting differences in their ability to inhibit HVA Ca 2ϩ currents. Whereas both (ϩ)-ECN and alphaxalone have relatively small effects on HVA Ca 2ϩ currents, (ϩ)-ACN seems to inhibit N-, Q-, and R-type currents with IC 50 values in the range of 5-20 M (Nakashima et al., 1998) . Thus, (ϩ)-ECN and alphaxalone seem to share similar effects on T-type current and HVA currents, but differ in their effects on GABA A receptors. The lack of effect of (ϩ)-ECN on HVA currents is also consistent with its lack of effect on inhibitory or excitatory synaptic currents. Does T current inhibition result in interesting clinical/behavioral effects?. Until recently, T current inhibition has been the primary proposed explanation for the anticonvulsant actions of the succinimides (Macdonald and McLean, 1986; Coulter et al., 1989a Coulter et al., , 1989b ). As noted above, this hypothesis has now been challenged by work that has failed to observe inhibition of T current by appropriate concentrations of ethosuximide (Leresche et al., 1998 ). Yet, an important role of T current in convulsant activity is also suggested by the role of T current in burst generation in thalamic neurons (Huguenard and Prince, 1992) and the fact that increases in T current amplitude seem to favor epileptic discharges (Tsakiridou et al., 1995) .
At present, whether inhibition of T currents may contribute to other clinically or behaviorally important alterations remains unknown. However, the present results with alphaxalone may support this possibility. Alphaxalone remains the only anesthetic steroid that has been widely used in human medicine. Interestingly, whereas T current blockade by alphaxalone occurs with an IC 50 value of 1.3 M, the reported values for alphaxalone in plasma during anesthesia in humans is in the range of 6.5-13 M (Sear and PrysRoberts, 1979) . This suggests that, in mammals, alphaxalone affects T current in subanesthetic concentrations and, thus, T current inhibition is occurring during the production of anesthesia. On the other hand, it would seem unlikely that T current inhibition per se would contribute to the production of anesthesia.
It is interesting to consider several other aspects of the clinical action of alphaxalone in relation to a possible role of T current blockade. Alphaxalone has been reported to be a more efficacious agent in treatment of intractable status epilepticus than classic GABAergic agents like barbiturates (Chin et al., 1979) . It is also more effective in suppressing epileptic activity in experimental models than thiopental and diazepam (DeRiu et al., 1987) . In addition, alphaxalone has been reported to have stronger analgesic effects than propofol and pentobarbital (Gilron and Coderre, 1996) . It is possible that these clinical effects of alphaxalone, which distinguish it from other general anesthetics, may result from effects on novel ion channel targets, perhaps T currents. Thus, T current inhibition by particular steroids may contribute both to anticonvulsant effects and analgesic consequences.
In conclusion, we have shown that several steroids inhibit T type Ca 2ϩ currents at submicromolar concentrations. Furthermore, one of these compounds, (ϩ)-ECN, produces these effects while exerting essentially no effects on GABA A receptors. The strong enantioselectivity in the blocking action of (ϩ)-ECN indicates that T channels probably contain a steroid binding site with well-defined structural features. Over the range of concentrations effective on T current, (ϩ)-ECN has essentially no effect on HVA Ca 2ϩ currents, voltage-dependent Na ϩ current, and some K ϩ currents at concentrations affecting T currents. (ϩ)-ECN and related compounds may prove useful in clarifying physiological and behavioral roles of T currents. Further work may lead to identification of compounds with even more potency and selectivity in blocking T currents.
